SunHo BioTech Group Statistics
Total Valuation
SGSH has a market cap or net worth of $135.28 million. The enterprise value is $139.74 million.
| Market Cap | 135.28M |
| Enterprise Value | 139.74M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SGSH has 33.82 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 33.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.74 |
| Forward PS | n/a |
| PB Ratio | 12.48 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.43% and return on invested capital (ROIC) is -8.11%.
| Return on Equity (ROE) | -9.43% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -8.11% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGSH had revenue of $4.40 million and -$1.05 million in losses. Loss per share was -$0.03.
| Revenue | 4.40M |
| Gross Profit | 3.25M |
| Operating Income | -1.43M |
| Pretax Income | -1.02M |
| Net Income | -1.05M |
| EBITDA | n/a |
| EBIT | n/a |
| Loss Per Share | -$0.03 |
Full Income Statement Balance Sheet
The company has $2.40 million in cash and $6.86 million in debt, giving a net cash position of -$4.46 million or -$0.13 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 6.86M |
| Net Cash | -4.46M |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 10.84M |
| Book Value Per Share | 0.32 |
| Working Capital | n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.18 million and capital expenditures -$96,791, giving a free cash flow of -$2.27 million.
| Operating Cash Flow | -2.18M |
| Capital Expenditures | -96,791 |
| Free Cash Flow | -2.27M |
| FCF Per Share | -$0.07 |
Full Cash Flow Statement Margins
Gross margin is 73.85%, with operating and profit margins of -32.60% and -23.87%.
| Gross Margin | 73.85% |
| Operating Margin | -32.60% |
| Pretax Margin | -23.22% |
| Profit Margin | -23.87% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -51.67% |